Your browser doesn't support javascript.
loading
PERK inhibitor, GSK2606414, ameliorates neuropathological damage, memory and motor functional impairments in cerebral ischemia via PERK/p-eIF2ɑ/ATF4/CHOP signaling.
Dhir, Neha; Jain, Ashish; Sharma, Amit Raj; Prakash, Ajay; Radotra, Bishan Das; Medhi, Bikash.
Afiliação
  • Dhir N; Department of Pharmacology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Jain A; Department of Pharmacology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Sharma AR; Department of Neurology, Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh, India.
  • Prakash A; Department of Pharmacology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Radotra BD; Department of Histopathology, Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh, India.
  • Medhi B; Department of Pharmacology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. drbikashus@yahoo.com.
Metab Brain Dis ; 38(4): 1177-1192, 2023 04.
Article em En | MEDLINE | ID: mdl-36847967

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de Iniciação 2 em Eucariotos / Isquemia Encefálica Limite: Animals Idioma: En Revista: Metab Brain Dis Assunto da revista: CEREBRO / METABOLISMO Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Índia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator de Iniciação 2 em Eucariotos / Isquemia Encefálica Limite: Animals Idioma: En Revista: Metab Brain Dis Assunto da revista: CEREBRO / METABOLISMO Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Índia